Deadline: 15-Nov-23
The Lung Ambition Alliance invites local patient organizations around the world to develop and submit pilot projects that can potentially transform patient care and improve survival at the local level.
ILC 2 is looking to fund innovative, promising, and proven projects around the world that can be supported and scaled to transform patient outcomes. It is deliberately ambitious, and they intend to learn throughout the program about what works in achieving their goal.
The program has been created in recognition of the high variation in lung cancer care management around the world and specific local barriers to quality patient-centric solutions.
The projects supported by the fund will help change the pace of progress in lung cancer survival, contributing to the goals of the Lung Ambition Alliance to improve 5-year survival rates and eliminate lung cancer as a leading cause of death.
This year, they are excited to include projects related to small-cell lung cancer (SCLC) within the broader grant program.
They aim to:
- Fund projects that drive measurable improvements across the patient journey, from early detection to palliative care or survivorship, in alignment with the Lung Ambition Alliance strategic pillar, Enhance Quality of Care.
- Have a positive impact on the quality of life of patients and caregivers involved in the projects.
- Learn about what really works, build the evidence base, and share that knowledge.
They hope to generate:
- Case studies and other evidence of promising approaches.
- Opportunities for future scaling and investment.
- A greater supply of effective interventions to improve access to screening, cutting-edge care, and survivorship.
Funding Information
- ILC2 offers 3 categories of funding, which vary according to the size of the applicant organisation, the starting point for your project, and the scale of reach and impact that you hope to achieve.
- Category 1: Requests up to USD $15,000
- Category 2: Requests up to USD $15,001–$25,000
- Category 3:Requests up to USD $25,001-USD $25,001-$75,000
Eligible Projects
- To achieve this, they are seeking grant applications for projects that:
- Are ambitious and aligned with the Lung Ambition Alliance’s objectives
- Focus on quality of care for patients at risk of, or living with, lung cancer
- Involve patients or focus on the experience and needs of patients or caregivers
- Have an evidence base, or are innovative and have an intention to build the evidence base, with potential for scaling or replication
- Engage patients in advocacy activities
- Provide peer-to-peer support
- Show potential to leverage future funding or infuence the care system to improve outcomes for patients
- Go beyond risk reduction to support patients at different stages after first diagnosis
- Take environmental factors into consideration at all stages of the patient journey when considering lung cancer care.
- Address disparities in diagnosis and treatment in order to improve outcomes for patients
- This year they also have a particular focus on Asia, in order to prioritise an underrepresented area in their support for lung cancer care.
Eligibility Criteria
- Grant applications are welcome from charitable or non-profit organisations worldwide which are involved in the care and support of patients with lung cancer. Organisations should be registered as a charity or non-profit in their country.
- Current ILC 2 grant holders may apply again this year, but only for a new program, not for an extension of their currently funded program as there is still much to learn from the existing projects. In addition, they wish to discover new and innovative improvements in lung cancer care.
- Priority will be given to projects that:
- Align to Lung Ambition Alliance objectives
- Are well thought through, with realistic and measurable outcomes
- Demonstrate a high potential for impact on patients
- Move from ideas into action or build on existing success
- Are innovative
- Have the potential to scale up or influence policy
- Are located in Asia
Ineligible
- Individuals, health care providers, medical group practices, and public officials
- Organisations that:
- Discriminate on the basis of age, race, color, religion, national origin, gender, sexual orientation, marital status, military service, veteran status, disability, or other unlawful basis
- Promote political or religious viewpoints to their beneficiaries
- Use the funds to make grants or donations to other organisations or individuals
- Are unable to supply bank details or report back on outcomes
- Are not registered as charitable or non-profit in their country
- Initiatives already funded through other AstraZeneca or Guardant Health programs (such as the Young Health Programme)
- Projects that provide treatment, diagnostic tests, or pay for medicines
- Medical research projects or projects which do not feature patient-care outcomes within the timescale of the grant
- Tobacco cessation programmes
- Projects that benefit AstraZeneca’s or Guardant Health’s commercial business
- Applications > $100,000 USD
- Projects which will cost significantly more than the grant amount
- Retrospective funding
- Capital projects or building appeals
- Any other activities prohibited under local standards
- Projects that have more than 50% income from other sources
For more information, visit The Lung Ambition Alliance.